https://www.selleckchem.com/pr....oducts/bms-986020.ht
ic/electrical instability or neuromuscular adverse events occurred. Treatment with infliximab might be associated with an increased risk of cardiovascular death. The need for IIST was more common in patients who developed myocarditis very early after the start of ICI therapy, as well as when hemodynamic/electrical instability or neuromuscular adverse events occurred. Treatment with infliximab might be associated with an increased risk of cardiovascular death. The therapeutic effect of immune checkpoint blockers, especially the neutra
Like
Comment
Share
